I 
117TH CONGRESS 
2D SESSION 
H. R. 8316 
To require reports, evaluations, and research by the Department of Homeland 
Security regarding drug interdiction along the border, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 7, 2022 
Ms. SPANBERGER (for herself and Mr. GARBARINO) introduced the following 
bill; which was referred to the Committee on Homeland Security, and in 
addition to the Committees on Oversight and Reform, Energy and Com-
merce, and the Judiciary, for a period to be subsequently determined by 
the Speaker, in each case for consideration of such provisions as fall with-
in the jurisdiction of the committee concerned 
A BILL 
To require reports, evaluations, and research by the Depart-
ment of Homeland Security regarding drug interdiction 
along the border, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Securing America’s 
Borders Against Fentanyl Act’’. 
VerDate Sep 11 2014 
02:53 Jul 09, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8316.IH
H8316
kjohnson on DSK79L0C42PROD with BILLS
SEC. 2. REPORTS, EVALUATIONS, AND RESEARCH REGARD-
ING DRUG INTERDICTION AT AND BETWEEN 
PORTS OF ENTRY. 
(a) RESEARCH ON ADDITIONAL TECHNOLOGIES TO 
DETECT FENTANYL.— 
(1) IN
GENERAL.—Not later than one year 
after the date of the enactment of this Act, the Sec-
retary of Homeland Security, in consultation with 
the Centers for Disease Control and Prevention, the 
Federal Drug Administration, and the Defense Ad-
vanced Research Projects Agency, shall research ad-
ditional technological solutions to— 
(A) target and detect illicit fentanyl and its 
precursors, including low-purity fentanyl, espe-
cially in counterfeit pressed tablets, and illicit 
pill press molds; 
(B) enhance targeting of counterfeit pills 
through nonintrusive, noninvasive, and other 
visual screening technologies; and 
(C) enhance data-driven targeting to in-
crease seizure rates of fentanyl and its precur-
sors. 
(2) AUTHORIZATION
OF
APPROPRIATIONS.— 
There is authorized to be appropriated to the Sec-
retary of Homeland Security to carry out this sub-
VerDate Sep 11 2014 
02:53 Jul 09, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8316.IH
H8316
kjohnson on DSK79L0C42PROD with BILLS
section $20,000,000 for each of fiscal years 2023 
through 2027. 
(b) EVALUATION OF CURRENT TECHNOLOGIES AND 
STRATEGIES IN ILLICIT DRUG INTERDICTION AND PRO-
CUREMENT DECISIONS.— 
(1) IN GENERAL.—The Secretary of Homeland 
Security, in consultation with the Administrator of 
the Drug Enforcement Administration, the Director 
of the Federal Bureau of Investigation, the Director 
of the Centers for Disease Control and Prevention, 
and the Commissioner of Food and Drugs, shall es-
tablish a program to collect available data and de-
velop metrics to measure how technologies and strat-
egies used by the Department, U.S. Customs and 
Border Protection, and other relevant Federal agen-
cies have helped detect, deter, or address illicit 
fentanyl and its precursors being trafficking into the 
United States at and between land, air, and sea 
ports of entry. Such data and metrics program may 
consider the rate of detection at random secondary 
inspections at such ports of entry, investigations and 
intelligence sharing into the origins of illicit fentanyl 
later detected within the United States, and other 
data or metrics considered appropriate by the Sec-
retary. The Secretary, as appropriate and in the co-
VerDate Sep 11 2014 
02:53 Jul 09, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8316.IH
H8316
kjohnson on DSK79L0C42PROD with BILLS
ordination with the officials specified in this para-
graph, may update such data and metrics program. 
(2) REPORTS.— 
(A) SECRETARY
OF
HOMELAND
SECU-
RITY.—Not later than one year after the date 
of the enactment of this Act and biennially 
thereafter, the Secretary of Homeland Security, 
the Administrator of the Drug Enforcement 
Administration, the Director of the Federal Bu-
reau of Investigation, the Director of the Cen-
ters for Disease Control and Prevention, the 
Commissioner of Food and Drugs, and the 
Postmaster General shall, based on the data 
collected and metrics developed pursuant to the 
program established under paragraph (1), sub-
mit to the Committee on Homeland Security of 
the House of Representatives and the Com-
mittee on Homeland Security and Govern-
mental Affairs a report that— 
(i) examines and analyzes current 
technologies deployed at land, air, and sea 
ports of entry, including pilot technologies, 
to assess how well such technologies detect, 
deter, and address fentanyl and its precur-
sors; 
VerDate Sep 11 2014 
02:53 Jul 09, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H8316.IH
H8316
kjohnson on DSK79L0C42PROD with BILLS
(ii) contains a cost-benefit analysis of 
technologies used in drug interdiction; and 
(iii) describes how such analysis may 
be used when making procurement deci-
sions relating to such technologies. 
(B) GAO.—Not later than one year after 
each report submitted pursuant to subpara-
graph (A), the Comptroller General of the 
United States shall submit to the Committee on 
Homeland Security of the House of Representa-
tives and the Committee on Homeland Security 
and Governmental Affairs of the Senate a re-
port that evaluates and, as appropriate, makes 
recommendations to improve, the data collected 
and metrics used in each such report. 
SEC. 3. ONDCP SUPPLEMENTAL STRATEGIES. 
Section 706(h) of the Office of National Drug Con-
trol Policy Reauthorization Act of 1998 (21 U.S.C. 
1705(h)) is amended— 
(1) in paragraph (5), by striking ‘‘; and’’ and 
inserting a semicolon; 
(2) in paragraph (6), by striking the period at 
the end and inserting ‘‘; and’’; and 
(3) by adding at the end the following new 
paragraph: 
VerDate Sep 11 2014 
02:53 Jul 09, 2022
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H8316.IH
H8316
kjohnson on DSK79L0C42PROD with BILLS
‘‘(7) develops performance measures and tar-
gets for the National Drug Control Strategy for sup-
plemental strategies (the Southwest Border, North-
ern Border, and Caribbean Border Counternarcotics 
Strategies) to effectively evaluate region-specific 
goals, to the extent the performance measurement 
system does not adequately measure the effective-
ness of the strategies, as determined by the Direc-
tor, such strategies may evaluate interdiction efforts 
at and between ports of entry, interdiction tech-
nology, intelligence sharing, diplomacy, and other 
appropriate metrics, specific to each supplemental 
strategies region, as determined by the Director.’’. 
Æ 
VerDate Sep 11 2014 
02:53 Jul 09, 2022
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H8316.IH
H8316
kjohnson on DSK79L0C42PROD with BILLS